Clinical and Molecular Staging of Lung Cancer Stages I and IIp
Clinical and Molecular Staging of Lung Cancer Stages I and IIp: Generation and Initial Analysis of a Clinical and Molecular Knowledge Database
Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER)
A observational or N/A phase clinical study on Lung Cancer, this trial is ongoing. The trial is conducted by Consorcio Centro de Investigación Biomédica en Red (CIBER) and has accumulated 14 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status
-
Dec 2021 — Mar 2023 [monthly]
Unknown Status
▶ Show 9 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Mar 2019 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
-
Oct 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Consorcio Centro de Investigación Biomédica en Red (CIBER)
- Corporacion Parc Tauli
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .